IMNM
Price
$8.77
Change
-$0.02 (-0.23%)
Updated
Jun 27 closing price
Capitalization
763.97M
45 days until earnings call
TCRX
Price
$1.40
Change
-$0.08 (-5.41%)
Updated
Jun 27 closing price
Capitalization
79.23M
45 days until earnings call
Interact to see
Advertisement

IMNM vs TCRX

Header iconIMNM vs TCRX Comparison
Open Charts IMNM vs TCRXBanner chart's image
Immunome
Price$8.77
Change-$0.02 (-0.23%)
Volume$1.07M
Capitalization763.97M
TScan Therapeutics
Price$1.40
Change-$0.08 (-5.41%)
Volume$5.4M
Capitalization79.23M
IMNM vs TCRX Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. TCRX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IMNM: $8.77 vs. TCRX: $1.40)
Brand notoriety: IMNM and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 120% vs. TCRX: 811%
Market capitalization -- IMNM: $763.97M vs. TCRX: $79.23M
IMNM [@Biotechnology] is valued at $763.97M. TCRX’s [@Biotechnology] market capitalization is $79.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 4 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than TCRX.

Price Growth

IMNM (@Biotechnology) experienced а +0.40% price change this week, while TCRX (@Biotechnology) price change was -2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($764M) has a higher market cap than TCRX($79.2M). IMNM YTD gains are higher at: -17.420 vs. TCRX (-53.947). TCRX has higher annual earnings (EBITDA): -124.58M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. TCRX (252M). IMNM has less debt than TCRX: IMNM (4.77M) vs TCRX (97M). IMNM has higher revenues than TCRX: IMNM (10.9M) vs TCRX (4.42M).
IMNMTCRXIMNM / TCRX
Capitalization764M79.2M965%
EBITDA-175.18M-124.58M141%
Gain YTD-17.420-53.94732%
P/E RatioN/AN/A-
Revenue10.9M4.42M247%
Total Cash317M252M126%
Total Debt4.77M97M5%
TECHNICAL ANALYSIS
Technical Analysis
IMNMTCRX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NHYKF5.760.11
+2.04%
Norsk Hydro ASA
ACOPF5.10N/A
N/A
A2 Milk Co Ltd.
HLYK0.02N/A
N/A
HealthLynked Corp.
DSBX15.20N/A
N/A
Dogwood State Bank RALEIGH NC
BKFAF7.01N/A
N/A
BROOKFIELD CORP.

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.23%
IDYA - IMNM
61%
Loosely correlated
-4.13%
ARWR - IMNM
56%
Loosely correlated
+0.06%
BEAM - IMNM
55%
Loosely correlated
-1.98%
RXRX - IMNM
55%
Loosely correlated
-6.85%
SYRE - IMNM
54%
Loosely correlated
-4.99%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-5.41%
FATE - TCRX
46%
Loosely correlated
-5.45%
CRBU - TCRX
44%
Loosely correlated
-5.19%
MGNX - TCRX
44%
Loosely correlated
-6.30%
IMNM - TCRX
43%
Loosely correlated
-0.23%
EYPT - TCRX
41%
Loosely correlated
-7.04%
More